New York, NY (PRWEB) January 28, 2014
Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, responds to a January 20, 2014 article that discusses a new ‘backdoor’ approach to treat glioblastoma – the most common and fatal form of brain cancer.
According to the January 20, 2014 article published by Futurity.org titled “‘Backdoor’ Approach May Stop Deadly Brain Tumors,” researchers have discovered a new way to inhibit the spreading of a certain enzyme that fuels the growth of glioblastoma – the most common and deadliest form of brain cancer. This new approach could lead not only to more effective treatments for the cancer but to treatments with fewer harmful side effects.
A new study, published in the Journal of Biological Chemistry, found that blocking the enzyme phospholipase D (PLD) with ‘newly invented’ compounds could shrink brain tumors in mice. PLD “regulates the oncogenic enzyme called Akt, which is important in cancer cell growth, proliferation, metabolism and survival.”
Michael Klipper, Chairman of Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, says this finding is a great step forward for the brain cancer community. “Hearing about these breakthrough discoveries that are happening every day in the medical world is truly amazing,” he says. “They provide hope that there will one day be a cure for this terrible disease, something that most in the brain cancer community have only dreamed about thus far.”
VABC has a wide variety of initiatives in place for brain cancer research, awareness and support. The organization’s research grants fund cutting-edge research programs that will have a monumental impact on the diagnosis and treatment of brain cancer. VABC currently funds research at several esteemed institutions such as Brookhaven National Laboratory, Cleveland Clinic, Columbia, Cornell, Duke, Harvard, Johns Hopkins, Memorial Sloan-Kettering and Yale, to name a few.
VABC's mission is to find a cure for brain cancer by advancing scientific research, increasing awareness within the medical community and supporting patients, their families and caregivers afflicted with this devastating disease.
For press inquiries, please contact: http://www.5wpr.com.